Where Tech Meets Bio | Andrii Buvailo | Substack

FDA’s AI Drug Development Guidelines and What’s Next for Biopharma M&A

Also: One-Third of Pharma Molecules Now Come from China, Weekly Highlights...

Jan 14 •

,

, and

Concluding 2024: Weekly Highlights #24

Legal Challenges of AI in Drug Discovery; Virtual Cells in Real Tissue; Disrupting In Vitro Fertilization Status Quo

Dec 30, 2024 •

and

Where Are We Now With AI-driven Drug Discovery?🎄

The new research article raises important questions to focus on in 2025...

Dec 27, 2024 •

and

Most Popular

Ex-NASA Expert Unveils Everything You Need to Know About Brain-Computer Interfaces

Apr 5, 2024 • Andrii Buvailo

The '4th Wave' of AI Drug Discovery is Here, According to This Report

Dec 12, 2024 • Andrii Buvailo

11 Biopharma Trends to Watch in 2024

Dec 29, 2023 • Andrii Buvailo

First Week Highlights of 2024

Jan 8, 2024

'Google Maps' of Human Cells

Nov 26, 2024 • BiopharmaTrend, Roman Kasianov, and Andrii Buvailo

Weekly Tech+Bio Highlights #13

Aug 20, 2024

Weekly Tech+Bio Highlights #23

ALSO: New EGFR-binding Proteins, Designing Novel IBD Treatment Using Gen-AI, Toward AI-Driven Digital Organism...

Dec 17, 2024 •

,

, and

The '4th Wave' of AI Drug Discovery is Here, According to This Report

I’ve come across a really well-put report on the evolving state of artificial intelligence (AI) in drug discovery in 2024 and beyond, authored by Chris…

Dec 12, 2024 •

Weekly Tech+Bio Highlights #21

ALSO: 100 Million-Cell Atlas for AI Drug Discovery, R&D Shifts in 2025, Miniprotein-based Therapeutics...

Dec 10, 2024 •

,

, and

Weekly Tech+Bio Highlights #20

ALSO: Mapping Pharma Innovation, Foundation Model for Radiology, Injectable Immune Organs vs. Ovarian Cancer, and More...

Dec 3, 2024 •

,

, and

'Google Maps' of Human Cells

ALSO: World Models in Biotech — the Next Frontier; Antibody Design Without Binders, Transforming Clinical Trial Recruitment, and more...

Nov 26, 2024 •

,

, and

Weekly Tech+Bio Highlights #19

ALSO: Generative AI vs. Fatal Lung Disease; This Company Claims New “Gold Standard“ for Microscopy Data Analysis; Rethinking Gene Delivery with ML, and…

Nov 19, 2024 •

,

, and

A New Kid On the Block: AI World Models In Biotech

LLMs are all the rage now, but they (likely) won't get us to real drug discovery revolution. So.. what's next?

Nov 14, 2024 •

and

Demis Hassabis on What's Next for AI in Biotech

ALSO: Adapting to Change in Clinical Development; AI is Key to Democratizing Drug Discovery; 10 Companies to Watch in Precision Medicine...

Nov 11, 2024 •

,

, and

On Predicting Probability of Technical and Regulatory Success With AI

Insights from The American Society of Clinical Oncology (ASCO) Annual Meeting 2024

Nov 7, 2024 •

Where Tech Meets Bio

Where Tech Meets Bio

What does the future hold for us in the “century of biotech“?

Recommendations

The Algorithmic Bridge

The Algorithmic Bridge

Alberto Romero

AI Supremacy

Michael Spencer

The Connected Ideas Project

The Connected Ideas Project

Alexander Titus

People vs Algorithms

People vs Algorithms

Troy Young

Special Competitive Studies Project

Special Competitive Studies Project

SCSP

Where Tech Meets Bio

About Archive Recommendations Sitemap

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts